M.B.X. Biosciences
Develops precision peptide therapies for endocrine and metabolic disorders.
$63.00
After-hours close+0.01 (+0.02%)
At close$62.99(−5.12%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.84 | — | — |
| Aug 2026 | −$0.63 | −$0.78 | −23.3% |
| May 2026 | −$0.62 | −$0.51 | +17.7% |
| Mar 2026 | −$0.64 | −$0.49 | +23.4% |
| Nov 2025 | −$0.73 | −$0.63 | +13.7% |
The latest year is open to everyone — the 8 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Sep 2024 | — | — | — |
| Aug 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.84 | — | — | — | — | — |
| Aug 6, 2026 | −$0.63 | −$0.78 | −23.3% | — | — | — |
| May 7, 2026 | −$0.62 | −$0.51 | +17.7% | — | — | — |
| Mar 12, 2026 | −$0.64 | −$0.49 | +23.4% | — | — | — |
| Nov 6, 2025 | −$0.73 | −$0.63 | +13.7% | — | — | — |
The latest year is open to everyone — the 8 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 17, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Sep 13, 2024 | — | — | — | — | — | — |
| Aug 23, 2024 | ||||||
| Dec 31, 2023 | ||||||
| Sep 30, 2023 | ||||||